November 2022

All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Hyperlipidemia. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. In this update, all statin medications offered in...

Vancouver, Canada (November 2, 2022) – GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in...